This is the authors' abstract. We don't add key points for this paper.
Antigen testing is an effective methodology for COVID-19 disease screening, and the receptor-binding domain of SARS-CoV-2 spike glycoprotein (RBD) is recognized as a key biomarker for the diagnosis, treatment, and...
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Han et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: